32 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Novus Therapeutics, Inc. NVUS rose 158.3% to $0.9790 in pre-market trading after the company reported the purchase of Anelixis Therapeutics.
• Marinus Pharmaceuticals, Inc. MRNS rose 60.2% to $3.38 in pre-market trading after the company announced Ganaxolone achieved its primary endpoint in Phase 3 trial for CDKL5 deficiency disorder and was generally well-tolerated.
• Lonestar Resources US Inc. LONE rose 38% to $0.37 in pre-market trading after the company announced a restructuring support agreement to eliminate $390 million in debt obligation and preferred equity interests.
• Town Sports International Holdings, Inc. CLUB rose 23.4% to $0.3948 in pre-market trading after the company filed voluntary petitions for relief under Chapter 11 bankruptcy.
• ARCA biopharma, Inc. ABIO shares rose 17.4% to $5.61 in pre-market trading after gaining over 5% on Monday. ARCA biopharma, last month, posted a loss for its second quarter.
• Sunworks, Inc. SUNW rose 13.8% to $0.87 in pre-market trading after gaining around 11% on Monday.
• América Móvil, S.A.B. de C.V. AMX rose 9.9% to $14.83 in pre-market trading after gaining around 8% on Monday. Verizon announced plans to acquire America Movil’s Tracfone for up to $6.9 billion.
• Immuron Limited IMRN rose 9.3% to $8.62 in pre-market trading.
• Harmony Gold Mining Company Limited HMY rose 8.8% to $6.73 in pre-market trading.
• Fiat Chrysler Automobiles N.V. FCAU rose 8.7% to $12.97 in pre-market trading after the company announced it has agreed to amend certain terms of its binding 50/50 combination agreement with Peugeot S.A. to create Stellantis.
• Lipocine Inc. LPCN rose 8.4% to $1.44 in pre-market trading after climbing around 10% on Monday. The FDA, last month, informed the company that it needs additional time to complete its review of TLANDO's new drug application.
• Cellectar Biosciences, Inc. CLRB rose 8.3% to $1.30 in pre-market trading. Cellectar recently reported data on CLR 131 Phase 2 CLOVER-1 study in triple class refractory multiple myeloma patients.
• Cars.com Inc. CARS rose 8.1% to $9.24 in pre-market trading after gaining over 6% on Monday.
• Future FinTech Group Inc. FTFT rose 7.7% to $2.38 in pre-market trading after the company signed an equity acquisition frame agreement with Benma (Shenzhen) Industrial Co.
• Seattle Genetics, Inc. SGEN rose 7.1% to $184.00 in pre-market trading. SVB Leerink maintained Seattle Genetics with an Outperform and raised the price target from $173 to $185. Seattle Genetics shares climbed 15% on Monday after the company announced it would collaborate with pharmaceutical giant Merck on two Oncology drugs and that Merck would invest $1 billion in the company.
• Seanergy Maritime Holdings Corp. SHIP rose 7% to $0.4598 in pre-market trading. Seanergy Maritime, last week, announced open-market stock purchase plan by the CEO of 500,000 common shares.
• Camping World Holdings, Inc. CWH rose 6.7% to $38.54 in pre-market trading after the company raised its FY21 EBITDA guidance.
• Murphy Oil Corporation MUR rose 6.5% to $10.86 in pre-market trading. MKM Partners, on Monday, upgrades Murphy Oil to Buy.
• NextEra Energy Inc NEE rose 6.5% to $300.10 in pre-market trading after the company raised its guidance for 2021 and 2022 and extended its longer-term growth forecast to 2023. The company’s board also approved a four-for-one stock split.
• Ideanomics, Inc. IDEX rose 5.7% to $1.28 in pre-market trading after surging 11% on Monday.
• Vivint Solar, Inc. VSLR rose 5% to $34.00 in pre-market trading after gaining over 6% on Monday.
• Tesla, Inc. TSLA shares rose 4% to $436.20 in pre-market trading in anticipation of the company's Battery day event next week. Additionally, the company reported an increase in car registrations for the month of August compared to July.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Qurate Retail, Inc. QRTEA fell 37% to $6.89 in pre-market trading. Qurate Retail reported upbeat quarterly results last month.
• Kraton Corporation KRA fell 8.8% to $16.06 in pre-market trading.
• Cassava Sciences, Inc. SAVA shares fell 6.6% to $7.24 in pre-market trading. Cassava Sciences shares surged 133% on Monday after the company announced results for a Phase 2b clinical study of Sumifilam in patients with Alzheimer's disease showed statistically significant improvements in biomarkers compared to placebo.
• Hancock Jaffe Laboratories, Inc. HJLI fell 6.4% to $0.4401 in pre-market trading after dropping around 17% on Monday. Hancock Jaffe, last month, announced one year follow-up data on two additional VenoValve patients.
• Humana Inc. HUM shares fell 6.4% to $377.90 in pre-market trading after rising over 3% on Monday.
• Nikola Corporation NKLA fell 6% to $33.67 in pre-market trading. After Monday's closing bell, Bloomberg reported the U.S. Securities and Exchange Commission is examining Nikola"to assess the merits of a short-seller's allegations that the electric-truck maker deceived investors about its business prospects, according to people familiar with the matter."
• Forterra Inc FRTA fell 5.1% to $16.50 in pre-market trading after the company announced secondary offering of 10 million shares. Forterra also reported voluntary prepayment of term loan.
• Vaxart, Inc. VXRT shares fell 5.1% to $7.38 in pre-market trading after jumping around 47% on Monday. Vaxart recently announced its oral COVID-19 vaccine candidate induces potent systemic and mucosal immune response in preclinical studies.
• PPD Inc PPD shares fell 4.6% to $32.26 in pre-market trading after the company announced a 38 million share secondary common stock offering.
• Miragen Therapeutics Inc MGEN fell 3.2% to $0.91 in pre-market trading after the company reported the resignation of its President and CEO, William Marshall. miRagen also announced plans to review strategic alternatives.